CEACAM5 and colorectal carcinoma: Circulating lymphocyte counts should be monitored during chemotherapy to guide individualized medicine in adjuvant chemotherapy of CRC, especially for those who have a pretreatment CEA ≥10 ng ml-1 or those >60 years old.